Your browser doesn't support javascript.
loading
AT1-receptor blockade with irbesartan improves peripheral but not coronary endothelial dysfunction in patients with stable coronary artery disease.
Warnholtz, Ascan; Ostad, Mir Abolfazl; Heitzer, Thomas; Thuneke, Felix; Fröhlich, Meike; Tschentscher, Peter; Schwedhelm, Edzard; Böger, Rainer; Meinertz, Thomas; Munzel, Thomas.
Affiliation
  • Warnholtz A; Department of Medicine II, Johannes Gutenberg-University Mainz, Langenbeckstrasse 1, 55101 Mainz, Germany. warnholt@uni-mainz.de
Atherosclerosis ; 194(2): 439-45, 2007 Oct.
Article in En | MEDLINE | ID: mdl-16970950
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Tetrazoles / Vasodilation / Biphenyl Compounds / Coronary Artery Disease / Brachial Artery / Coronary Vessels / Angiotensin II Type 1 Receptor Blockers Type of study: Clinical_trials / Diagnostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Atherosclerosis Year: 2007 Type: Article Affiliation country: Germany
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Tetrazoles / Vasodilation / Biphenyl Compounds / Coronary Artery Disease / Brachial Artery / Coronary Vessels / Angiotensin II Type 1 Receptor Blockers Type of study: Clinical_trials / Diagnostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Atherosclerosis Year: 2007 Type: Article Affiliation country: Germany